Clinical trial
Efficacy of the Fentanyl Transdermal Therapeutic System (TTS) in the Management…
NCT00269737 · Alza Corporation, DE, USA, Industry · Completed
Key facts
| NCT number | NCT00269737 |
|---|---|
| Title | Efficacy of the Fentanyl Transdermal Therapeutic System (TTS) in the Management of Pain in Patients With Cancer |
| Official title | Efficacy of TTS Fentanyl in the Management of Pain in Patients With Malignancy - Study III |
| Lead sponsor | Alza Corporation, DE, USA, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Pain, Cancer |
| Intervention type | Drug |
| Interventions | Fentanyl Transdermal Therapeutic System (TTS) |
| Enrollment | 7 |
| Start date | May 1, 1986 |
| Completion | Feb 1, 1988 |
| First posted | Dec 26, 2005 |
| Last update posted | May 19, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: